Showing results (1-10 of 409) with videos related to

Sort By:
Pageof 41
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 23, 2023
[Non-Small Cell Lung Cancer]Ken Yamamoto, Akito Hata
JTO Clinical and Research Reports|August 18, 2025
Tocilizumab for Steroid Pulse-Refractory Cytokine Release Syndrome in Chemotherapy With Durvalumab Plus Tremelimumab for NSCLC: A Case ReportKen Yamamoto, Katsuya Hirano, Temiko Shimada, et al.
Thoracic Cancer|April 16, 2024
Continuous immunotherapy beyond progression in clinical practice for small cell lung cancerKen Yamamoto, Taira Ninomaru, Hideaki Okada, et al.
Annals of Vascular Diseases|April 17, 2024
Limb Salvage Surgery for Ponatinib-Induced Bilateral Chronic Limb-Threatening Ischemia in a Patient with Chronic Myeloid Leukemia with T315I Mutation in BCR-ABL: A Case ReportTakuo Nomura, Akito Hata
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 12, 2021
[How to Preserve QOL of Patients with Small Cell Lung Cancer-Cutting‒Edge Treatment of Brain and Bone Metastases]Taira Ninomaru, Akito Hata
Internal Medicine (Tokyo, Japan)|August 19, 2014
Bevacizumab for critical brain metastases in a patient with pulmonary pleomorphic carcinomaAkito Hata, Shiro Fujita, Kenji Takayama, et al.
Thoracic Cancer|July 6, 2022
Heterogeneity or transformation? A whack-a-mole case of EGFR-mutant lung adenocarcinoma and small cell carcinoma: A case reportTaira Ninomaru, Akito Hata, Shigeo Hara, et al.
Frontiers in Immunology|May 27, 2024
Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximabShion Kachi, Shuji Sumitomo, Hideki Oka, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2013
Dose reduction or intermittent administration of erlotinib: which is better for patients suffering from intolerable toxicities?Akito Hata, Shiro Fujita, Reiko Kaji, et al.
Advances in Therapy|July 11, 2024
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese PatientsAkito Hata, Shunichiro Iwasawa, Yusuke Sasaki, et al.
Pageof 41